journal article·2013-08-27

Assessing Clinical Prospects of Silicon Quantum Dots: Studies in Mice and Monkeys

Jianwei Liu, Folarin Erogbogbo, Ken-Tye Yong, Ling Ye, Jing Liu, Rui Hu, Hongyan Chen, Yazhuo Hu, Yi Yang, Jinghui Yang, Indrajit Roy, Nicholas A. Karker, Mark T. Swihart, Paras N. Prasad

ACS Nano· Volume 7· Issue 8
Publisher page

Abstract

Silicon nanocrystals can provide the outstanding imaging capabilities of toxic heavy-metal-based quantum dots without employing heavy metals and have potential for rapid progression to the clinic. Understanding the toxicity of silicon quantum dots (SiQDs) is essential to realizing this potential. However, existing studies of SiQD biocompatibility are limited, with no systematic progression from small-animal to large-animal studies that are more clinically relevant. Here, we test the response of both mice and monkeys to high intravenous doses of a nanoconstruct created using only SiQDs and FDA-approved materials. We show that (1) neither mice nor monkeys show overt signs of toxicity reflected in their behavior, body mass, or blood chemistry, even at a dose of 200 mg/kg. (2) This formulation did not biodegrade as expected. Elevated levels of silicon were present in the liver and spleen of mice three months post-treatment. (3) Histopathology three months after treatment showed adverse effects of the nanoformulation in the livers of mice, but showed no such effects in monkeys. This investigation reveals that the systemic reactions of the two animal models may have some differences and there are no signs of toxicity clearly attributable to silicon quantum dots.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Quantum Dots Synthesis And Properties · Carbon and Quantum Dots Applications · Silicon Nanostructures and Photoluminescence

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Gerontology and Geriatrics, Chinese PLA General Hospital, Beijing 100853, People’s Republic of China

Institute for Lasers, Photonics and Biophotonics, University at Buffalo, The State University of New York, Buffalo, New York 14260-4200, United States

San Jose State University, San Jose, California 95192, United States

School of Electrical and Electronic Engineering, Nanyang Technological University, Nanyang Avenue, Singapore 639798, Singapore

Department of Chemical and Biological Engineering, University at Buffalo, The State University of New York, Buffalo, New York 14260-4200, United States

Department of Chemistry, Korea University, Seoul 136-701, Korea

References (38)

Show source-provided references
1. Prasad P. N. · 2012
2. Derfus A. M. · Nano Lett. · 2003 · 4 · 1110.1021/nl0347334 ↗
3. Hardman R. · Environ. Health Perspect. · 2006 · 114 · 16510.1289/ehp.8284 ↗
4. Hauck T. S. · Small · 2010 · 6 · 13810.1002/smll.200900626 ↗
5. Ye L. · Nat. Nanotechnol. · 2012 · 7 · 45310.1038/nnano.2012.74 ↗
6. Pons T. · ACS Nano · 2010 · 4 · 253110.1021/nn901421v ↗
7. Yang M. · Angew. Chem., Int. Ed. · 2011 · 50 · 259710.1002/anie.201006849 ↗
8. Park J.-H. · Nat. Mater. · 2009 · 8 · 33110.1038/nmat2398 ↗
9. Colvin V. L. · Nat. Biotechnol. · 2003 · 21 · 116610.1038/nbt875 ↗
10. Plumlee G. S. · Rev. Mineral. Geochem. · 2006 · 64 · 510.2138/rmg.2006.64.2 ↗
11. Cai W. · Nano Lett. · 2006 · 6 · 66910.1021/nl052405t ↗
12. Erogbogbo F. · ACS Nano · 2011 · 5 · 41310.1021/nn1018945 ↗
13. Buriak J. M. · Chem. Rev. · 2002 · 102 · 127110.1021/cr000064s ↗
14. Carlisle E. M. · Science · 1972 · 178 · 61910.1126/science.178.4061.619 ↗
15. Canham L. T. · Nanotechnology · 2007 · 18 · 18570410.1088/0957-4484/18/18/185704 ↗
16. Carlisle E. M. · In Ciba Found. Symp. · 1986 · 121 · 123
17. Choi J. · J .Appl. Toxicol. · 2009 · 29 · 5210.1002/jat.1382 ↗
18. Durnev A. D. · Bull. Exp. Biol. Med. · 2010 · 149 · 44510.1007/s10517-010-0967-3 ↗
19. Ivanov S. · Materials · 2012 · 5 · 187310.3390/ma5101873 ↗
20. Wang Q. · Adv. Healthcare Mater. · 2012 · 1 · 18910.1002/adhm.201100010 ↗
21. Maier-Flaig F. · Nano Lett. · 2013 · 13 · 47510.1021/nl3038689 ↗
22. de Boer W. D. A. M. · Nat. Nanotechnol. · 2010 · 5 · 87810.1038/nnano.2010.236 ↗
23. Chrobak D. · Nat. Nanotechnol. · 2011 · 6 · 48010.1038/nnano.2011.118 ↗
24. Erogbogbo F. · Nano Lett. · 2013 · 13 · 45110.1021/nl304680w ↗
25. Selvan S. T. · Adv. Mater. · 2005 · 17 · 162010.1002/adma.200401960 ↗
26. Gerion D. · J. Phys. Chem. B · 2001 · 105 · 886110.1021/jp0105488 ↗
27. Fujioka K. · Nanotechnology · 2008 · 19 · 41510210.1088/0957-4484/19/41/415102 ↗
28. Alsharif N. H. · Small · 2009 · 5 · 22110.1002/smll.200800903 ↗
29. Code of Federal Regulations Title 21. 2012; Vol. 3, Cite: 21CFR172.515.
30. Hu R. · RSC Adv. · 2013 · 3 · 849510.1039/c3ra23169k ↗
31. Seok J. · Proc. Natl. Acad. Sci. U.S.A. · 2013
32. Rice J. · Nature · 2012 · 484 · S910.1038/nature11102 ↗
33. Keelan J. A. · Nat. Nanotechnol. · 2011 · 6 · 26310.1038/nnano.2011.65 ↗
34. Heidel J. D. · Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 571510.1073/pnas.0701458104 ↗
35. Fox S. H. · Movement Disord. · 2006 · 21 · 157810.1002/mds.20936 ↗
36. LeWitt P. A. · Lancet Neurol. · 2011 · 10 · 30910.1016/S1474-4422(11)70039-4 ↗
37. Himeno A. · Vaccine · 2010 · 28 · 537710.1016/j.vaccine.2010.04.110 ↗
38. Li X. · Langmuir · 2004 · 20 · 472010.1021/la036219j ↗